miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2

Yosuke Harazono1, Tomoki Muramatsu, Hironori Endo

  • 1Department of Molecular Cytogenetics, Tokyo Medical and Dental University, Tokyo, Japan.

Plos One
|May 22, 2013
PubMed

Insights

MicroRNA-655 (miR-655) suppresses cancer progression by inhibiting the epithelial-to-mesenchymal transition (EMT). This novel EMT-suppressive miRNA targets ZEB1 and TGFBR2, offering potential therapeutic strategies for cancers like esophageal squamous cell carcinoma.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • The epithelial-to-mesenchymal transition (EMT) is implicated in normal development and disease, notably cancer progression.
  • Identifying microRNAs (miRNAs) that suppress EMT is crucial for understanding and potentially treating cancer.

Purpose of the Study:

  • To discover novel microRNAs (miRNAs) that inhibit the epithelial-to-mesenchymal transition (EMT).
  • To investigate the role of miR-655 in cancer cell migration, invasion, and prognosis.

Main Methods:

  • Established a cell-based reporter system using Panc1 pancreatic cancer cells and a CDH1/E-cadherin promoter-driven reporter construct.
  • Conducted a functional screen of 470 synthetic microRNA mimics to identify EMT-suppressive miRNAs.
  • Validated targets and assessed the impact of miR-655 overexpression on cancer cell phenotype, migration, invasion, and prognosis.

Main Results:

  • Identified miR-655 as a novel EMT-suppressive miRNA.
  • Overexpression of miR-655 upregulated E-cadherin, downregulated EMT-inducers, and suppressed cancer cell migration and invasion.
  • Found a correlation between higher miR-655 expression and better prognosis in esophageal squamous cell carcinoma (ESCC).
  • Identified ZEB1 and TGFBR2 as direct targets of miR-655, implicating the TGF-b signaling pathway.

Conclusions:

  • miR-655 acts as a tumor suppressor by inhibiting EMT, targeting key components of the TGF-b signaling pathway (ZEB1, TGFBR2).
  • Aberrant downregulation of miR-655 may accelerate cancer progression through activation of the TGF-b-ZEB1-E-cadherin axis.
  • miR-655 represents a potential therapeutic target for cancers exhibiting EMT, including esophageal squamous cell carcinoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...